Abcellera Biologics Inc
F:8QQ
Abcellera Biologics Inc
F:8QQ
Price:
5.65
EUR
-4.07%
Market Closed
Market Cap:
€1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Abcellera Biologics Inc
F:8QQ
|
CA |
|
J
|
Jinhui Shipping and Transportation Ltd
OSE:JIN
|
HK |
|
C
|
Commercial Metals Co
F:CMS
|
US |
|
A
|
Alibaba Health Information Technology Ltd
F:TWYA
|
HK |
|
L
|
LyondellBasell Industries NV
F:DLY
|
UK |
|
T
|
Teleperformance SE
DUS:RCF
|
FR |
|
A
|
Aiful Corp
SWB:AAU
|
JP |
|
F
|
First Commonwealth Financial Corp
F:FCF
|
US |
|
I
|
International Flavors & Fragrances Inc
F:IFF
|
US |
Wall St Price Targets
8QQ Price Targets Summary
Abcellera Biologics Inc
Abcellera Biologics Inc
Wall Street analysts forecast 8QQ stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 8QQ is 6.13 EUR with a low forecast of 4.07 EUR and a high forecast of 7.86 EUR.
Lowest Forecast
Price Target
4.07
EUR
28% Downside
Average Forecast
Price Target
6.13
EUR
8% Upside
Highest Forecast
Price Target
7.86
EUR
39% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8QQ's stock price target?
Price Target
6.13
EUR
6.13
EUR
According to Wall Street analysts, the average 1-year price target for 8QQ is 6.13 EUR with a low forecast of 4.07 EUR and a high forecast of 7.86 EUR.
What is the Revenue forecast for Abcellera Biologics Inc?
Projected CAGR
33%
33%
Over the last 6 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 33%.
